Ovid Therapeutics (OVID) Operating Income Growth (5y) (2021 - 2026)
Ovid Therapeutics (OVID) Operating Income Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.01% |
| Dec 31, 2025 | 10.65% |
| Sep 30, 2025 | 5.26% |
| Jun 30, 2025 | 26.18% |
| Mar 31, 2025 | 9.16% |
| Dec 31, 2024 | 9.09% |
| Sep 30, 2024 | 4.63% |
| Jun 30, 2024 | -9.02% |
| Mar 31, 2024 | -4.38% |
| Dec 31, 2023 | -6.74% |
| Sep 30, 2023 | 1.80% |
| Jun 30, 2023 | -1.42% |
| Mar 31, 2023 | -2.09% |
| Dec 31, 2022 | -1.96% |
| Sep 30, 2022 | -6.36% |
| Jun 30, 2022 | -6.81% |
| Mar 31, 2022 | 13.84% |
| Dec 31, 2021 | -28.27% |
| Sep 30, 2021 | -14.97% |
| Jun 30, 2021 | -21.45% |